Skip to main content
OpenTrials
Completed

NCT Number: NCT03825224

Evaluation of MyoStrain™ in Clinical Practice

Evaluate MyoStrain cardiac MRI pulse sequence in Clinical practice

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cardiac Failure Amyloidosis Arterial Occlusive Diseases Arteriosclerosis Cardiomyopathies Cardiovascular Diseases Chemically-Induced Disorders Coronary Artery Disease Coronary Disease Drug Toxicity Drug-Related Side Effects and Adverse Reactions Heart Diseases Heart Failure Hemic and Lymphatic Diseases Hypersensitivity Hypersensitivity, Delayed Immune System Diseases Lupus Lymphatic Diseases Lymphoproliferative Disorders Metabolic Diseases Myocardial Ischemia Myocarditis Nutritional and Metabolic Diseases Proteostasis Deficiencies Sarcoidosis Vascular Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

The University of Kansas Medical Center

Kansas City, Kansas, 66160, United States

About this study

Evaluate MyoStrain cardiac MRI pulse sequence in Clinical practice to determine how the use may alter treatment decisions and clinical outcomes in patients who are undergoing cardiac MRI.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients already scheduled for diagnostic testing with commercially available imaging modality (cardiac MRI)
  • The patient population will include (but not limited to), those being evaluated for heart disease and heart failure that may be related to vascular disease (coronary artery disease), drug related heart failure (chemotherapy, alcohol), inflammatory systemic conditions (sarcoidosis, amyloidosis, lupus), myocarditis, and/or infectious etiologies
  • Provided written informed consent

Exclusion criteria

  • Contraindication to Magnetic Resonance Imaging

Treatment and study plan

Diagnostic Test: Myostrain

Procedure

This test measures the contraction of the heart muscle in one to three heartbeats per plane. It's a pulse sequence that produces images that reveal the underlying contraction fo the muscle of a healthy heart and associated weaknesses in case of disease.

Primary outcomes

  1. Evaluate workflow for MyoStrain testing

    Time frame: Baseline

    Survey the CMR interpreter to see how Myostrain impacted their interpretation and survey the referring clinician after receiving the CMR report.

    Survey Questions using 5-point Likert and binary reporting scale. The lower numbers represent positive feedback. Example listed below:

    CARDIAC MRI INTERPRETATION QUESTIONS FOR READER (CARDIOLOGIST OR RADIOLOGIST)

    How easy was it to interpret the additional Myostrain sequence information? 1 2 3 4 5

    (1=Very Helpful 2=Helpful 3=Indifferent 4=Unhelpful 5=Very Unhelpful)

Sponsors and collaborators

Lead sponsor

University of Kansas Medical Center

Other

Registry information

Important dates

Study start
2019
Primary completion
2019
Study completion
2019
First posted
Jan 31, 2019
Registry last updated
Nov 19, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.